← Back to Search

Sling Device

AdVance for Stress Incontinence

N/A
Waitlist Available
Research Sponsored by Jewish General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

The study is designed to assess efficacy and subject satisfaction of two sling devices: Advance and Argus, in male patients with stress urinary incontinence after prostatectomy.

Eligible Conditions
  • Stress Incontinence

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: AdVanceActive Control1 Intervention
sling procedure
Group II: ARGUSActive Control1 Intervention
sling procedure

Find a Location

Who is running the clinical trial?

Jewish General HospitalLead Sponsor
140 Previous Clinical Trials
278,440 Total Patients Enrolled
Center Hospitalier de Fleurimont,Sherbrooke UniversityUNKNOWN
Sunnybrook Health Sciences CentreOTHER
674 Previous Clinical Trials
1,565,727 Total Patients Enrolled
~10 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top